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S U M M A R Y
The purpose of this study was to describe the emergence of cutaneous leishmaniasis in a district of Sri
Lanka, documented at the national level as having zero incidence. We analyzed data from the Sri Lanka
Army (SLA) to describe reported cases of cutaneous leishmaniasis for all armed forces personnel located
in all 24 districts of Sri Lanka. These data are not included in the National Surveillance System. From
January 2011 through February 2013, 314 armed forces personnel were conﬁrmed as having
leishmaniasis. Of these, 223 (81.4%) were working within the district of Mullaitivu at the time of
investigation and another 21 (6.5%) reported that the lesion ﬁrst appeared when they were working in
Mullaitivu. The reported cumulative annual incidence of leishmaniasis among the army population was
7.5 per 10 000, while in the general area of Mullaitivu the incidence was 234 per 10 000. Leishmaniasis is
emerging in epidemic proportions in Mullaitivu and is still not detected through the public health
surveillance system. Urgent attention directed at disease surveillance and control activities is needed to
control this emerging public health threat.
 2014 International Society for Infectious Diseases. Published by Elsevier Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Since the ﬁrst report of a locally acquired case in 1992,1
cutaneous leishmaniasis (CL) has emerged as one of the most
important communicable diseases in Sri Lanka.2 In 2008,
leishmaniasis was listed as a notiﬁable disease in Sri Lanka.
Laboratory-based research reports and surveillance data show that
the disease is endemic in the districts of Hambantota, Anuradha-
pura,3 Polonnaruwa,4 and Matara.5 According to the weekly
epidemiological reports published by the epidemiology unit of
Sri Lanka, ﬁve districts, namely Mullaitivu, Mannar, Jaffna,
Batticaloa, and Badulla did not report a single case during the
period 2010–2012.6 Of these districts, four were affected by 30
years of conﬂict, and the public health infrastructure and
healthcare services are still developing.
The control and prevention of neglected tropical diseases are
severely affected in most low-resource settings due to the lack of
diagnostic facilities. In some of the zero incidence districts, the
services of a dermatologist were not available during that period* Corresponding author.
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creativecommons.org/licenses/by-nc-nd/3.0/).and we hypothesized that the true picture of CL is not represented
by the routinely reported data. In contrast, the Sri Lanka Army
(SLA) has a good public health surveillance system covering the
armed services personnel deployed all over the island, and
leishmaniasis has been included as a notiﬁable disease in this
surveillance system since 2011.
The disease investigation and screening process within the SLA
is uniform at all their locations. Due to the problem of including a
resident health division with a mobile population, SLA data are not
included in the national ﬁgures published by the epidemiology
unit in Sri Lanka. This non-inclusion of SLA data may have led to a
gross underestimation of the disease burden in the country, as
shown during the hepatitis A outbreak in Vanni, Sri Lanka in 2009.7
2. Study subjects and methods
Data for the present paper were derived from the SLA public
health surveillance system for the period January 2011 to February
2013.
Case detection in SLA was done passively until 2012. In 2012, it
was noted that one base camp was experiencing a higher
incidence, and as a result, active case detection was done in that
particular division located in Pudukuduiruppu area, in the districtier Ltd. This is an open access article under the CC BY-NC-ND license (http://
Figure 2. Temporal distribution of reported leishmaniasis cases in the Sri Lanka
Army, January 2011 to February 2013.
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clinically with CL. Of these, 25 (96%) were conﬁrmed as having CL
through the demonstration of amastigotes in slit skin smears,
showing a very high predictive value of clinical diagnosis.
Subsequent cases were diagnosed and reported, based on the
clinical diagnosis made by the dermatologist (second author). This
is also the current practice in the Sri Lankan National Surveillance
System, in which routine diagnosis and treatment are based on
clinical grounds.
3. Results
From January 2011 through February 2013, 314 patients were
conﬁrmed as having leishmaniasis. The number of cases reported
in 2011, 2012, and 2013 (February) was 149, 109, and 56 cases,
respectively. The current place of work and work history were
available for 274 cases. Of these, 223 (81.4%) were working within
the district of Mullaitivu at the time of the investigation. Others
were from Jaffna (n = 10, 3.7%), Colombo (n = 10, 3.7%), Kilinochchi
(n = 8, 2.9%), Polonnaruwa (n = 6, 2.2%), Anuradhapura (n = 5, 1.8%),
Vavuniya (n = 5, 1.8%), and ﬁve other districts (n = 7, 2.2%). Of the 51
cases located in bases outside the district of Mullaitivu, 21 (6.5%)
reported that the lesion had ﬁrst appeared while they were located
in Mullaitivu. The reported cumulative annual incidence of
leishmaniasis among the SLA personnel was 7.5 per 10 000, while
in the general area of Mullaitivu the incidence was 234 per 10 000
(Figure 1).
The temporal distribution of cases showed case reporting
throughout the year (Figure 2). A sudden increase in cases was seenFigure 1. Leishmaniasis risk map based on cases reported from the Sri Lanka Army.in the last quarter of 2012 and the ﬁrst quarter of 2013, due to
active case detection through screening.
4. Discussion
While the surveillance of leishmaniasis in Sri Lanka depends on
the availability of a dermatologist in the particular district, the SLA
mobilizes the dermatologist to all base camps and this allows
uniform surveillance throughout the country. Hence, the spatial
distribution of cases in the SLA is not expected to be biased by the
availability of a dermatologist.
The observations made in this population have major implica-
tions for leishmaniasis control in Sri Lanka. The SLA has a
workforce of 200 000 and around 5000 soldiers are stationed in the
Mullaitivu area. Since the end of the conﬂict in the north and east of
the country in 2009, these soldiers have mostly been stationed in
the same camp and so have not formed a mobile population. The
number of cases from the district of Mullaitivu as shown in this
study makes it one of the highest case loads in Sri Lanka. Even
though the geographic location of the source of infection for a few
cases may have been a district other than Mullaitivu due to a
change in location, the majority of the cases were conﬁrmed as
having been stationed in that area for more than 6 months.
It would be expected that the clustering of cases in Mullaitivu
would be associated with vector abundance and local spread of the
disease. Previous studies have also suggested that the distribution
of CL in Sri Lanka could be widespread8 and may not be truly
represented by the present surveillance system. It is unlikely that
only the armed forces are affected in those areas, with civilians
spared. The locations of these bases are in the middle of civilian
populations. We suspect that the disease could be highly prevalent
among the population residing in Mullaitivu and that it might be of
epidemic proportions. We strongly recommend the active
surveillance of leishmaniasis in these new resettlements to reduce
the burden of this important disease. In addition, this study clearly
shows the challenges faced by the disease surveillance systems in
resource-poor settings due to lack of awareness and diagnostic
facilities.
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